Suppr超能文献

设计、合成及评价 N-苯甲酰基吲唑衍生物及类似物作为人中性粒细胞弹性蛋白酶抑制剂。

Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase.

机构信息

Dipartimento di Scienze Farmaceutiche, Università degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy.

出版信息

Bioorg Med Chem. 2011 Aug 1;19(15):4460-72. doi: 10.1016/j.bmc.2011.06.036. Epub 2011 Jul 7.

Abstract

Human neutrophil elastase (HNE) plays an important role in tumour invasion and inflammation. A series of N-benzoylindazoles was synthesized and evaluated for their ability to inhibit HNE. We found that this scaffold is appropriate for HNE inhibitors and that the benzoyl fragment at position 1 is essential for activity. The most active compounds inhibited HNE activity with IC₅₀ values in the submicromolar range. Furthermore, docking studies indicated that the geometry of an inhibitor within the binding site and energetics of Michaelis complex formation were key factors influencing the inhibitor's biological activity. Thus, N-benzoylindazole derivatives and their analogs represent novel structural templates that can be utilized for further development of efficacious HNE inhibitors.

摘要

人中性粒细胞弹性蛋白酶 (HNE) 在肿瘤侵袭和炎症中发挥重要作用。我们合成了一系列 N-苯甲酰基吲哚,并评估了它们抑制 HNE 的能力。我们发现该支架适合 HNE 抑制剂,并且 1 位的苯甲酰片段对于活性是必需的。最活跃的化合物以亚微摩尔范围内的 IC₅₀ 值抑制 HNE 活性。此外,对接研究表明抑制剂在结合部位的几何形状和 Michaelis 复合物形成的能学是影响抑制剂生物学活性的关键因素。因此,N-苯甲酰基吲哚衍生物及其类似物代表了可用于进一步开发有效 HNE 抑制剂的新型结构模板。

相似文献

1
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase.
Bioorg Med Chem. 2011 Aug 1;19(15):4460-72. doi: 10.1016/j.bmc.2011.06.036. Epub 2011 Jul 7.
2
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase.
J Med Chem. 2013 Aug 8;56(15):6259-72. doi: 10.1021/jm400742j. Epub 2013 Jul 25.
3
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase.
Drug Dev Res. 2019 Aug;80(5):617-628. doi: 10.1002/ddr.21539. Epub 2019 Apr 19.
4
Cinnoline derivatives as human neutrophil elastase inhibitors.
J Enzyme Inhib Med Chem. 2016 Aug;31(4):628-39. doi: 10.3109/14756366.2015.1057718. Epub 2015 Jul 21.
5
Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors.
Bioorg Med Chem. 2021 Jan 1;29:115836. doi: 10.1016/j.bmc.2020.115836. Epub 2020 Nov 6.
7
Isoxazol-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors.
J Enzyme Inhib Med Chem. 2017 Dec;32(1):821-831. doi: 10.1080/14756366.2017.1326915.
8
1H-pyrrolo[2,3-b]pyridine: A new scaffold for human neutrophil elastase (HNE) inhibitors.
Bioorg Med Chem. 2018 Nov 15;26(21):5583-5595. doi: 10.1016/j.bmc.2018.09.034. Epub 2018 Sep 27.
9
Sesquiterpene lactones as inhibitors of human neutrophil elastase.
Bioorg Med Chem. 2002 Sep;10(9):2855-61. doi: 10.1016/s0968-0896(02)00149-9.
10
Design and synthesis of peptide-based carboxylic acid-containing transition-state inhibitors of human neutrophil elastase.
Bioorg Med Chem Lett. 2002 Feb 25;12(4):551-5. doi: 10.1016/s0960-894x(01)00797-1.

引用本文的文献

2
Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation.
Materials (Basel). 2021 Jun 10;14(12):3217. doi: 10.3390/ma14123217.
3
Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors.
Bioorg Med Chem. 2021 Jan 1;29:115836. doi: 10.1016/j.bmc.2020.115836. Epub 2020 Nov 6.
4
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors.
Front Chem. 2020 Sep 1;8:795. doi: 10.3389/fchem.2020.00795. eCollection 2020.
5
Novel and Modified Neutrophil Elastase Inhibitor Loaded in Topical Formulations for Psoriasis Management.
Pharmaceutics. 2020 Apr 14;12(4):358. doi: 10.3390/pharmaceutics12040358.
7
Cinnoline Scaffold-A Molecular Heart of Medicinal Chemistry?
Molecules. 2019 Jun 18;24(12):2271. doi: 10.3390/molecules24122271.
8
A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications.
Expert Opin Ther Pat. 2019 Jul;29(7):555-578. doi: 10.1080/13543776.2019.1630379. Epub 2019 Jun 16.
9
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase.
Drug Dev Res. 2019 Aug;80(5):617-628. doi: 10.1002/ddr.21539. Epub 2019 Apr 19.
10
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors.
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1108-1124. doi: 10.1080/14756366.2018.1480615.

本文引用的文献

1
Semiempirical Comparative Binding Energy Analysis (SE-COMBINE) of a Series of Trypsin Inhibitors.
J Chem Theory Comput. 2006 Mar;2(2):383-99. doi: 10.1021/ct050284j.
2
Neutrophil elastase inhibitors.
Expert Opin Ther Pat. 2011 Mar;21(3):339-54. doi: 10.1517/13543776.2011.551115. Epub 2011 Jan 16.
3
Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis.
World J Gastroenterol. 2010 Dec 14;16(46):5790-800. doi: 10.3748/wjg.v16.i46.5790.
4
Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment.
Eur J Med Res. 2010 Nov 4;15 Suppl 2(Suppl 2):27-35. doi: 10.1186/2047-783x-15-s2-27.
6
Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.
Pharmacol Rev. 2010 Dec;62(4):726-59. doi: 10.1124/pr.110.002733.
7
Intracellular processing of alpha1-antitrypsin.
Proc Am Thorac Soc. 2010 Nov;7(6):376-80. doi: 10.1513/pats.201001-011AW.
8
Serine proteases of the human immune system in health and disease.
Mol Immunol. 2010 Jul;47(11-12):1943-55. doi: 10.1016/j.molimm.2010.04.020. Epub 2010 May 26.
10
Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury.
Bioorg Med Chem. 2009 Nov 1;17(21):7477-86. doi: 10.1016/j.bmc.2009.09.020. Epub 2009 Sep 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验